Uncontrolled movements in Parkinson's disease
Parkinson's disease is a disorder that can involve several different kinds of uncontrolled movements. Some are caused by the disease, such as tremor and gait freezing, while dyskinesia – uncontrolled jerking or twisting movement – is caused by long-term levodopa use. We unpack how dyskinesia affects movement in Parkinson’s disease and how it’s usually treated.
How levodopa can impact uncontrolled movements in Parkinson’s disease
Carbidopa-levodopa is a drug combination that works to reduce symptoms in Parkinson's disease for as long as a patient takes it. Levodopa converts into dopamine in the brain, helping to control movement, while carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain.
In Parkinson's, dopamine-producing brain cells are lost and dopamine levels decrease, leading to disease symptoms. Levodopa effectively treats motor symptoms, such as tremors, stiffness, and slowness of movement by crossåing into the brain through what is referred to as the blood/brain barrier. It is combined in medications with carbidopa, which slows the breakdown of levodopa in the bloodstream so more medication can reach the brain. Carbidopa can also reduce nausea and vomiting, common levodopa side effects.
While effective at managing some symptoms, it does not slow or stop disease progression or treat non-motor symptoms like sleep issues and depression.
As the underlying disease progresses and symptoms get worse, patients may need to increase their dose or take levodopa more frequently to experience the same reduction in symptoms. Patients may experience what is referred to as "off" time when the medication wears off before it's time for another levodopa dose. "Off" time can lead to motor fluctuations as well as the return of other symptoms.
Some people with Parkinson's choose to delay starting levodopa treatment. They may start by taking a dopamine agonist, a treatment option that is less powerful than levodopa/carbidopa but is also less likely to cause dyskinesia. Treatment decisions are personal for everyone living with Parkinson's, and ideally should be discussed with a medical specialist.
What causes dyskinesia in Parkinson's disease?
Unlike "off" time, patients typically experience dyskinesia in Parkinson's when medications are working and other symptoms are under control. Researchers aren't exactly sure what causes dyskinesia, but it is believed to be a side effect of long-term levodopa use, not a symptom itself. Levodopa-induced dyskinesia (sometimes referred to as LID) can look like fidgeting, writhing, wriggling, head bobbing, or body swaying. LID can sometimes be confused with Parkinson's tremor, which is a back and forth shaking caused by the disease.
Because levodopa is taken throughout the day, dopamine levels in the brain rise and fall. These fluctuating levels of dopamine combined with the continued loss of dopamine in the brain make it difficult to maintain regular dopamine levels, and lead to dyskinesia.
Individuals diagnosed with Parkinson's at a younger age are more likely to experience dyskinesia. It's also more common in later stages of Parkinson's or in those who have taken levodopa for several years.
Is tardive dyskinesia a symptom of Parkinson's disease?
Tardive dyskinesia is not a symptom of Parkinson's disease. It's a separate movement disorder caused by long-term use of anti-psychotic medications.
In addition to being a side effect of different medications, tardive dyskinesia also has its own set of symptoms. The movements associated with tardive dyskinesia tend to be more fluid in appearance compared with Parkinson's dyskinesia.
- Chlorpromazine (Thorazine or Largactil)
- Fluphenazine (Prolixin, Modecate, or Moditen)
- Haloperidol (Haldol)
- Perphenazine (Trilafon, Etrafon, Triavil, or Triptafen)
- Prochlorperazine (Compro, Darbazine, or Neo Darbazine)
- Thioridazine (Mellaril)
- Trifluoperazine (Stelazine or Stelbid)
Dystonia vs. dyskinesia in Parkinson's disease
Dystonia can refer to a Parkinson's symptom, a type of dyskinesia caused by levodopa side effects, or an entirely separate movement disorder. In general, dystonia is a sustained or repetitive muscle twisting. When muscle twisting and cramping last longer compared with normal dyskinesias, it can be referred to as dystonic dyskinesia.
When it's a Parkinson's symptom, dystonia can be treated with levodopa and physical therapy. Deep brain stimulation (DBS) surgery may also help dystonia symptoms in Parkinson's.
If you're unsure whether your muscle cramping or twisting is caused by Parkinson's or your medications, consider keeping track of your symptoms in a journal or on your phone. If you experience twisting when your other symptoms are well-managed, it may be dyskinesia. If cramping happens during "off" time, your dystonia may be a symptom of Parkinson's.
Dystonia is also a movement disorder that can occur without a Parkinson's disease diagnosis. Symptoms include uncontrollable muscle contractions that can lead to uncomfortable postures, foot-dragging, and other symptoms. Both the movement disorder dystonia and Parkinson's disease originate in the same part of the brain – the basal ganglia – which could be one reason symptoms are related.
How is dyskinesia treated in Parkinson's disease?
If dyskinesia is interfering with your daily life, talk with your neurologist or movement disorder specialist. Because they are trained specifically in conditions like Parkinson's, movement disorder specialists are best equipped to recognize the signs of dyskinesia and help explore treatment options.
To prepare for your appointment, keep a symptom diary and make note of your medication dose timing. You can also consider asking a friend or family member to take a video of you when you believe you're experiencing dyskinesia so you can show your doctor.
- Changing the dose/timing of levodopa: For some people with Parkinson's, lowering the dose of levodopa can help control dyskinesia while still managing motor symptoms.
- Switching to extended-release or gel infusion levodopa: Treatment options such as Rytary (extended-release levodopa) and Duodopa (an intestinal gel infusion of levodopa) can help keep dopamine levels steady in some patients and help manage dyskinesia.
- Amantadine: Gocovri (amantadine extended-release) was approved in the U.S. in 2017 to treat Parkinson's disease dyskinesia. The treatment works on the glutamate brain system to reduce dyskinesia symptoms. In countries where Gocovri has not been approved, patients may still be prescribed immediate-release amantadine.
- Deep brain stimulation (DBS): This surgical treatment option for Parkinson's disease can be an option for patients who experience significant "off" time and dyskinesia with levodopa treatment.
- Stress relief: Stress and strong emotions can make dyskinesia worse. While reducing stress is easier said than done, try to find techniques that help you personally relax, such as exercise, meditation, or reading a book.
Participating in clinical trials helps create the treatments of tomorrow. Start your search for a local Parkinson’s disease clinical trial opportunity.